Cite
MLA Citation
Ramiro L Gutierrez et al.. “632. A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers' Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD).” Open forum infectious diseases, vol. 7, n.d., p. S376. http://access.bl.uk/ark:/81055/vdc_100121987975.0x00000f